Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2023

Abstract Left ventricular assist device (LVAD) implantation is an established treatment for patients with advanced heart failure refractory to medical therapy. However, the incidence of ventricular arrhythmias (VAs) is high in this population, both in the acute and delayed phases after implantation.

Arrhythmia 75

Arrhythmia Heart Failure Ablation Outcomes 75

The American Journal of Cardiology

JUNE 11, 2024

Publication date: Available online 11 June 2024 Source: The American Journal of Cardiology Author(s): Steven Brady, Eldon Matthia, Steve Antoine, Juan Aranda, William Miles, Juan Vilaro, Mohammad Al-Ani, Olusola Oduntan, Yi Guo, Yujia Li, Mustafa Ahmed, Alex Parker

Heart Failure 52

Heart Failure Arrhythmia Outcomes 52

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background Echocardiography-guided percutaneous intramyocardial alginate-hydrogel implantation (PIMAHI) is a novel treatment approach for heart failure (HF). During PIMAHI treatment, no sustained arrhythmia, pericardial, or pleural effusion occurred. We validated PIMAHI safety and efficacy in canine HF models. vs. 6.8 ± 0.2 mm,

Heart Failure 64

Heart Failure Outcomes Bicuspid/Mitral Arrhythmia 64

DAIC

APRIL 24, 2025

tim.hodson Thu, 04/24/2025 - 10:37 April 23, 2025 The Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients. million adults. million adults.

52

52

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). The coexistence of these conditions can further induce structural changes and result in worsened outcomes such as stroke, HF decompensation, poorly controlled AF, and mortality [1].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

Cardiac resynchronization (CRT) with biventricular pacing (BVP) is recognized as an option to reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF). Left bundle branch area pacing (LBBAP) is an emerging role in achieving resynchronization in HFrEF and is thought to be a safe alternative to BVP.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

HeartRhythm

APRIL 30, 2024

Genetic predisposition to ventricular scarring is associated with heart failure and ventricular arrhythmia. Although many pathogenic variants have been shown to predispose patients to poor outcomes, the impact of many VUS remains uncharacterized.

Genetic predisposition 40

Genetic predisposition Heart Failure Arrhythmia Cardiomyopathy 40

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Abstract Aims The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

Heart BMJ

MAY 10, 2024

Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.

Arrhythmia 40

Arrhythmia Myocardial Infarction Atrial Fibrillation Heart Failure 40

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

MIBHS

JANUARY 15, 2025

Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Smokings Impact on Surgery When heart surgery is necessary, smoking complicates both the procedure and recovery.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Blood Clot Blood Pressure Plaque 52

Cardiology Update

JANUARY 2, 2024

European Heart Rhythm Association (EHRA) Congress Date: April 7-9, 2024 Location: Berlin, Germany and online Overview: The yearly gathering of the European Heart Rhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias. Hashtag: #ESCPrev2024 5.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. The clinical outcomes of catheter ablation and medical therapy were compared using the propensity score matched method. years following catheter ablation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Leon added, “This new mitral-tricuspid valve center will mobilize a decade of specialized experiences among our contributing physicians to provide optimal clinical outcomes for our sickest patients.”

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

Dr. Smith's ECG Blog

JULY 11, 2024

At this point, there was no improvement in LV function and he was out of the convalescent phase of his MI, so the decision was made to install an ICD for arrhythmia prophylaxis. He now has regular appointments with the heart failure team. The R waves have not recovered, however.

Outcomes 112

Outcomes Stenosis Outpatient Echocardiogram 112

HeartRhythm

MARCH 31, 2025

AF, the most common arrhythmia in adults, contributes to outcomes such as heart failure and stroke. Despite this, many underlying molecular mechanisms remain to be elucidated.

40

40

HeartRhythm

MARCH 31, 2025

Ventricular arrhythmias are common in adult and pediatric patients (pts) with end-stage heart failure requiring ventricular assist devices (VADs). Studies assessing the utility of implantable cardiac defibrillator (ICD) placement in adult patients with VADs show conflicting data regarding its mortality benefit.

40

40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, leading to significant cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is a well-established treatment for rhythm control in patients with AF.

40

40

Journal of the American Heart Association

DECEMBER 24, 2024

Cardiovascular composite end points included major adverse cardiovascular events plus (a composite end point of allcause mortality, myocardial infarction, stroke, or heart failure) and cardiac arrhythmias (a composite end point of new onset atrial fibrillation and other atrial and ventricular arrythmias), all in the hospital setting.

Kidney Disease 45

Kidney Disease Arrhythmia Myocardial Infarction Atrial Fibrillation 45

HeartRhythm

APRIL 30, 2024

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).

Atrial Flutter 40

Atrial Flutter Atrial Fibrillation Tachycardia Cardiomyopathy 40

Circulation

NOVEMBER 11, 2024

change in PC, initiation or escalation of diuretics, mortality, arrhythmias, heart failure hospitalization) over a 5-year period were obtained through chart review.Results:Deterioration of PC was significantly associated with worsening of all strain measures (p ≤0.05 Clinical events (e.g.,

Outcomes 40

Outcomes Congenital Physiology Heart Failure 40

CardiacWire

SEPTEMBER 25, 2024

That could have a major impact on cardiogenic shock outcomes, which rely heavily on blood pressure, and are associated with long/costly hospital stays and high mortality risks. That could be a big deal in the cardiogenic shock space, which many believe is still in need of more effective treatments.

Cardiogenic Shock 59

Cardiogenic Shock Blood Pressure Heart Failure Cardiac Function 59

Heart BMJ

DECEMBER 20, 2023

Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke. Once AF is initiated, the arrhythmia itself can further stimulate above pathways, creating a vicious cycle that allows arrhythmia perpetuation and progression from paroxysmal to non-paroxysmal types.

Blood Pressure 40

Blood Pressure Atrial Fibrillation Risk Factors Hypertension 40

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

Journal of the American Heart Association

DECEMBER 29, 2023

ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure.

Obesity 45

Obesity Atrial Fibrillation Heart Failure Pharmacology 45

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundIschemic cardiomyopathy (ICM) is the end stage of ischemic heart disease, in which ventricular remodeling contributes to a fatal ventricular arrhythmia, worsens heart function and unfavorable outcomes, and is related to persistent chronic inflammation.

Electrophysiology 45

Electrophysiology Ultrasound Cardiomyopathy Arrhythmia 45

Circulation

NOVEMBER 11, 2024

The risks of all-cause mortality and major adverse cardiac and cerebrovascular events (CVA, cardiac arrest, acute heart failure (AHF), Ventricular arrhythmia, complete AV block, AMI, and PCI), and use of mechanical circulatory support (MCS) were assessed in adult AMC admissions with and without SID.

Hospital 40

Hospital Outcomes Cardiac Arrest Heart Failure 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:A growing number of patients with tetralogy of Fallot develop left ventricular systolic dysfunction and heart failure, in addition to right ventricular dysfunction. years) with tetralogy of Fallot and CRT were enrolled.

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

DAIC

JULY 30, 2024

The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients and the primary information resource on heart rhythm disorders. Avari Silva On Saturday, Sept. Lakkireddy | Edmondo Robinson | Jose Osorio | Rod Passman | David N.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

Journal of Cardiovascular Pharmacology

FEBRUARY 26, 2025

Indeed, chronic inflammation and immune dysregulation play pivotal roles in most cardiovascular conditions, including arrhythmias, atherothrombosis, ischemic heart disease, heart failure, and valve disease. Copyright 2025 Wolters Kluwer Health, Inc. All rights reserved.

Pharmacology 40

Pharmacology Quality of Life Innovation Technology 40

DAIC

DECEMBER 19, 2023

OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. FACC, FHRS, FHSC , Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. billion (2).

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Circulation

NOVEMBER 11, 2024

We collected demographic, pre-procedural, procedural, and outcome-related variables. The most common MAE was arrhythmia, representing 46% of MAE, followed by cardiac arrest and bleeding each 20%. The leading cause of mortality was heart failure in 51% of deceased patients. were females. MAE was present in 1.6%.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

DAIC

JUNE 18, 2024

Smith Center for Outcomes Research in Cardiology and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center in Boston, Mass. Kazi , vice chair of the advisory writing group, said in an AHA news release. Kazi is head of health economics and associate director of the Richard A. and Susan F.

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

Cardiometabolic Health Congress

AUGUST 30, 2024

This discussion explores the principles and practices of evidence-based cardiometabolic medicine, emphasizing the importance of integrating the latest research findings into clinical decision-making to improve patient outcomes. Heart Failure : Home-based cardiac rehabilitation is as effective as center-based programs.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

Circulation

MARCH 11, 2024

In adults, arrhythmias such as atrial fibrillation and flutter are the most frequent acute cardiovascular complication. Acute heart failure has an incidence ranging from 0.4% In pediatric patients, left ventricular systolic dysfunction and pericardial effusion are the most common cardiovascular complications.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45